Emiko Tsugami
Overview
Explore the profile of Emiko Tsugami including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
22
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ito H, Someya R, Ando S, Araki R, Tsugami E, Matsumoto S, et al.
Hepatol Res
. 2023 Dec;
54(6):513-524.
PMID: 38141029
Aim: The efficacy of titratable fixed-ratio combination therapy by a combination preparation of insulin degludec and liraglutide (IDegLira) in Japanese patients with type 2 diabetes, focusing particularly on the change...
2.
Ito H, Matsumoto S, Izutsu T, Kusano E, Nishio S, Antoku S, et al.
Diabetes Metab Syndr Obes
. 2019 Oct;
12:1783-1794.
PMID: 31571954
Purpose: The factors associated with the renal prognosis over six months after the initiation of empagliflozin were compared between the non-elderly and elderly Japanese patients with type 2 diabetes. Patients...
3.
Ito H, Ando S, Tsugami E, Araki R, Kusano E, Matsumoto S, et al.
Diabetes Res Clin Pract
. 2019 Jun;
153:41-48.
PMID: 31150724
Aims: The changes in patients' satisfaction with the treatment, medication adherence and unused drugs before and after switching from daily DPP-4 inhibitors to once-weekly trelagliptin administration were prospectively investigated in...
4.
Ito H, Tsugami E, Ando S, Araki R, Matsumoto S, Uemura K, et al.
J Drug Assess
. 2018 Sep;
7(1):54-60.
PMID: 30202634
We compared the clinical course of type 2 diabetic patients whose basal insulin preparations were replaced from insulin glargine (IGlar) 100 units/mL (U100) to IGlar biosimilar or IGlar 300 units/mL...
5.
Ito H, Tsugami E, Ando S, Imai A, Matsumoto S, Omoto T, et al.
J Clin Med Res
. 2016 Sep;
8(10):710-4.
PMID: 27635175
Background: We investigated the trends in the clinical characteristics and prescriptions of type 2 diabetic patients with severe hypoglycemia because the prescription rate of antidiabetic agents has significantly changed recently....
6.
Ito H, Mifune M, Abe M, Oshikiri K, Antoku S, Takeuchi Y, et al.
BMC Nephrol
. 2012 Jun;
13:48.
PMID: 22738384
Background: We investigated 1) the frequency of hypertension in patients with type 2 diabetes graded by the new classification of chronic kidney disease (CKD) reported by the Kidney Disease: Improving...